MedTrace Logo

Imaging of Islet Transplantation With PET and MRT

NCT00417131 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2011-08-04

No results posted yet for this study

Summary

Islets of Langerhans intended for clinical transplantation are labelled with a radioactive tracer. The tracer is retained in viable cells of the transplant. At infusion (transplantation) of the islets into the portal vein the tracer can be followed for two hours with positron emission tomography (PET). Imaging and calculations can give estimates of the proportion of surveying islets and the rate of early destruction. Also the distribution of the islets into the liver can be viewed.

Conditions

  • Islet Transplantation
  • Diabetes Type 1

Sponsors & Collaborators

  • Uppsala University Hospital

    lead OTHER

Principal Investigators

  • Gunnar Tufveson, Professor · Dept of Transplantation, Uppsala University Hospital

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00417131 on ClinicalTrials.gov